Point-of-Care Diagnostics Market to Reach USD 43.7 Billion by 2036, Driven by Rising Demand for Rapid Testing and Home-Based Healthcare Solutions

The global point-of-care diagnostics market was valued at USD 19.1 Billion in 2025 and is projected to reach USD 43.7 Billion by 2036, expanding at a CAGR of 7.8% from 2026 to 2036. The market is witnessing substantial growth due to the increasing prevalence of chronic and infectious diseases, growing demand for rapid diagnostic solutions, and rising adoption of decentralized healthcare services across hospitals, clinics, and home-care settings.

→Discover Market Opportunities - Request Your Sample Copy Now: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1128

Analysts’ Viewpoint on the Global Point-of-Care Diagnostics Market

The point-of-care (PoC) diagnostics market continues to evolve as healthcare providers increasingly prioritize rapid diagnosis, early disease detection, and decentralized healthcare delivery models. Point-of-care testing has become a critical component of modern healthcare systems by enabling immediate diagnostic results that support faster clinical decision-making without reliance on centralized laboratory infrastructure.

Growing incidences of chronic diseases such as diabetes, cardiovascular disorders, and respiratory illnesses, coupled with increasing prevalence of infectious diseases, continue to drive demand for rapid and accessible diagnostic solutions. Healthcare facilities are increasingly adopting PoC diagnostic technologies to improve patient outcomes, reduce turnaround times, and optimize resource utilization.

Technological advancements in biosensors, molecular diagnostics, microfluidics, artificial intelligence, and connected healthcare platforms are significantly enhancing the accuracy, portability, and efficiency of PoC diagnostic devices. These innovations are enabling broader adoption across hospitals, clinics, physician offices, and home-care environments.

Despite strong growth prospects, the market faces challenges including high costs associated with advanced diagnostic systems, reimbursement limitations in certain regions, and concerns regarding diagnostic accuracy compared with centralized laboratory testing. However, continued technological improvements and growing healthcare investments are expected to mitigate these barriers over time.

Emerging economies offer substantial opportunities as healthcare infrastructure expands and awareness regarding preventive healthcare and early diagnosis continues to increase. The growing popularity of home testing kits, telemedicine platforms, and remote patient monitoring solutions is further strengthening market growth worldwide.

Point-of-Care Diagnostics Market Introduction

Point-of-care diagnostics, commonly referred to as bedside testing, near-patient testing, rapid diagnostics, mobile testing, or remote testing, involves conducting diagnostic tests at or near the site of patient care.

Unlike traditional laboratory testing methods that require samples to be transported and analyzed in centralized facilities, point-of-care diagnostics provide immediate results, allowing healthcare professionals to make faster clinical decisions.

These diagnostic solutions are widely utilized across numerous medical applications, including infectious disease testing, glucose monitoring, cardiovascular disease management, pregnancy testing, coagulation monitoring, oncology diagnostics, and respiratory disease detection.

The key benefits of point-of-care diagnostics include reduced turnaround time, improved patient outcomes, enhanced accessibility, lower healthcare costs, and better disease management, particularly in remote, underserved, and resource-limited settings.

The market is benefiting from ongoing technological innovation, increasing patient preference for convenient testing options, and growing emphasis on personalized healthcare delivery.

Rising Prevalence of Chronic and Infectious Diseases Driving Market Growth

One of the primary factors fueling the growth of the point-of-care diagnostics market is the increasing prevalence of chronic and infectious diseases worldwide.

The growing burden of diabetes, cardiovascular diseases, respiratory disorders, kidney diseases, and cancer is creating substantial demand for rapid and reliable diagnostic solutions. Early diagnosis plays a critical role in improving treatment outcomes, reducing healthcare costs, and minimizing disease progression.

Point-of-care diagnostic systems enable healthcare providers to perform testing directly at the patient care location, significantly reducing delays associated with laboratory-based testing. This capability is particularly valuable in emergency care settings, intensive care units, primary healthcare facilities, and rural healthcare environments.

The rising incidence of infectious diseases has further highlighted the importance of rapid diagnostic testing. Point-of-care testing enables timely identification of infectious agents, supports faster treatment decisions, and helps reduce disease transmission.

Additionally, ageing populations worldwide are contributing to increased demand for continuous health monitoring solutions such as glucose meters, cardiac biomarker tests, and coagulation monitoring devices.

As healthcare systems increasingly prioritize preventive care and early disease detection, adoption of point-of-care diagnostic technologies is expected to continue rising throughout the forecast period.

Growing Adoption of Home-Based Testing and Remote Patient Monitoring

The increasing acceptance of home-based healthcare solutions represents another major growth driver for the point-of-care diagnostics market.

Patients increasingly prefer convenient testing solutions that allow them to monitor health conditions without frequent visits to hospitals, laboratories, or physician offices. Home-based diagnostic kits enable individuals to monitor blood glucose levels, pregnancy status, cholesterol levels, infectious diseases, and various chronic health conditions from the comfort of their homes.

This trend is reducing healthcare system burdens while improving patient engagement and treatment compliance.

The expansion of remote patient monitoring technologies is further accelerating market growth. Connected diagnostic devices can transmit real-time patient data directly to healthcare providers, enabling continuous monitoring and timely clinical interventions.

Remote monitoring solutions are particularly valuable for managing chronic conditions such as diabetes, cardiovascular diseases, and respiratory disorders that require ongoing observation and regular health assessments.

The rapid growth of telemedicine services has also increased demand for connected diagnostic tools that facilitate virtual consultations and remote clinical decision-making.

As healthcare delivery models increasingly shift toward home-based and virtual care environments, demand for point-of-care diagnostics is expected to grow significantly.

Market Opportunity: Integration of Digital Health, Artificial Intelligence, and Smartphone-Based Diagnostics

The integration of digital health technologies, artificial intelligence (AI), and smartphone-based diagnostic platforms presents one of the most significant growth opportunities in the point-of-care diagnostics market.

AI-powered diagnostic systems are enhancing diagnostic accuracy by automating result interpretation, supporting risk assessment, and providing predictive analytics. These capabilities help reduce human error and improve clinical decision-making.

Digital health platforms enable real-time data collection, analysis, storage, and sharing, allowing healthcare professionals to monitor patient health continuously and remotely.

Smartphone-based diagnostic platforms are becoming increasingly popular due to their portability, affordability, and accessibility. Many modern diagnostic devices can connect directly to smartphones through dedicated applications, enabling users to conduct tests, receive results, and share information with healthcare providers seamlessly.

These technologies are particularly beneficial in rural and underserved areas where access to advanced healthcare infrastructure may be limited.

The integration of digital diagnostics with telemedicine services further enhances healthcare accessibility and supports more efficient patient management.

As healthcare systems worldwide continue their digital transformation initiatives, AI-enabled and smartphone-integrated point-of-care diagnostics are expected to become increasingly important drivers of market growth.

→Explore Strategies & Trends - Request Full Report Access – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1128

OTC Products Segment Leads the Market

The Over-the-Counter (OTC) products segment accounted for the largest share of the point-of-care diagnostics market, representing approximately 62.5% of total revenue in 2025.

Consumers increasingly prefer self-testing solutions that offer convenience, privacy, and immediate results. Growing awareness regarding preventive healthcare and personal health management has contributed significantly to the popularity of OTC diagnostic products.

The widespread availability of OTC testing kits through retail pharmacies, digital pharmacies, e-commerce platforms, and healthcare stores has improved accessibility for consumers across urban and rural regions.

Technological advancements have also improved the accuracy, reliability, and ease of use of OTC diagnostic kits, increasing consumer confidence in self-testing solutions.

Regulatory agencies in several countries have expanded approvals for OTC diagnostic products, further broadening product availability and supporting market expansion.

As healthcare systems continue to emphasize patient-centered care and self-management strategies, the OTC products segment is expected to maintain its dominant position throughout the forecast period.

North America Dominates the Global Point-of-Care Diagnostics Market

North America held the largest share of the global point-of-care diagnostics market in 2025, accounting for approximately 42.3% of total market revenue.

The region benefits from advanced healthcare infrastructure, high healthcare expenditure, strong regulatory support, and widespread adoption of innovative diagnostic technologies.

The United States and Canada have witnessed substantial adoption of point-of-care testing solutions across hospitals, clinics, ambulatory care centers, physician offices, and home-care settings.

The increasing prevalence of chronic diseases such as diabetes, cardiovascular disorders, and respiratory illnesses continues to drive demand for rapid diagnostic solutions throughout the region.

Growing consumer awareness regarding preventive healthcare and early disease detection further supports market growth. Favorable reimbursement policies and supportive regulatory frameworks have also encouraged adoption of innovative diagnostic technologies.

The expansion of telemedicine services, remote patient monitoring programs, and home healthcare solutions continues to strengthen demand for connected point-of-care diagnostic devices across North America.

Ongoing investments in research and development by major industry participants are expected to sustain the region’s leadership position during the forecast period.

Competitive Landscape

The point-of-care diagnostics market is highly competitive, with leading companies focusing on product innovation, technological advancement, strategic collaborations, and geographic expansion.

Manufacturers are investing heavily in molecular diagnostics, biosensor technologies, digital health integration, and artificial intelligence applications to enhance diagnostic accuracy and improve patient outcomes.

Companies are also expanding their product portfolios to address growing demand across infectious disease testing, chronic disease monitoring, home healthcare, and telemedicine applications.

Strategic partnerships, acquisitions, and regulatory approvals continue to shape the competitive landscape.

Key Companies Operating in the Market

Major companies operating in the global point-of-care diagnostics market include:

Abbott, BD, Bio-Rad Laboratories, Inc., bioMérieux SA, Cardinal Health Inc., Danaher Corporation, EKF Diagnostics Holdings plc, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., Nova Biomedical, Quidel Corporation, Siemens Healthcare GmbH, Thermo Fisher Scientific, Inc., Trinity Biotech Plc.

Recent Developments

In May 2025, SEKISUI Diagnostics launched a new rapid diagnostic testing solution designed for the detection of Respiratory Syncytial Virus (RSV) in professional healthcare settings.

In March 2025, Visby Medical received U.S. FDA De Novo authorization for its Women's Sexual Health Test for OTC use, enabling rapid at-home testing for Chlamydia, Gonorrhea, and Trichomoniasis.

In April 2025, DexCom received U.S. FDA clearance for its Dexcom G7 15-Day Continuous Glucose Monitoring System, designed for adults with diabetes and offering enhanced glucose monitoring accuracy and performance.

Future Outlook

The global point-of-care diagnostics market is expected to experience strong growth through 2036 as healthcare systems increasingly prioritize rapid diagnosis, decentralized care delivery, and patient-centered healthcare solutions.

Technological advancements in molecular diagnostics, artificial intelligence, digital health integration, and smartphone-enabled testing platforms will continue to transform the diagnostic landscape. Growing adoption of home-based healthcare solutions, telemedicine services, and remote patient monitoring programs will further accelerate demand.

As healthcare providers and patients increasingly seek faster, more accessible, and cost-effective diagnostic solutions, point-of-care diagnostics will remain a critical component of modern healthcare systems worldwide.

Buy Full Report Now: https://www.transparencymarketresearch.com/checkout.php?rep_id=1128<ype=S

→Explore Latest Research Reports by Transparency Market Research:

Plant Based Butter Market

Electric Vehicle Market

Fiber Optic Cable Market

Data Converters Market

Electric Bike Accessories Market

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Media Contact: 

Abhishek Budholiya

Transparency Market Research Inc.

State Tower, 90 State Street, Suite 700,

Albany NY - 12207, United States

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com 

Sales Inquiries: sales@transparencymarketresearch.com

Media Inquiries: media@transparencymarketresearch.com